ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2014
A functional and protein-protein interaction analysis of neuroepithelial cell transforming gene 1 in hepatocellular carcinoma.
Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 11 citations in OpenAlex.
- Src stimulates Abl-dependent phosphorylation of the guanine exchange factor Net1A to promote its cytosolic localization and cell motility.The Journal of biological chemistry · 2023Article
- miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer.OncoTargets and therapy · 2019Review
- A structural study of the complex between neuroepithelial cell transforming gene 1 (Net1) and RhoA reveals a potential anticancer drug hot spot.The Journal of biological chemistry · 2018Article
- Association between HLA-DQ Gene Polymorphisms and HBV-Related Hepatocellular Carcinoma.Gastroenterology research and practice · 2017Review
- Genetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016Article
- Genetic polymorphisms in antioxidant enzyme genes and susceptibility to hepatocellular carcinoma in Chinese population: a case-control study.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In our previous study, we reported that the expression of neuroepithelial transforming gene 1 (NET1) was increased in hepatocellular carcinoma (HCC) tissues and suggested that NET1 may serve as a novel prognostic predictor and a useful target for HCC therapy. The aim of this study was to determine the role of NET1 in HCC by monitoring the proliferation, migration, invasion, and metastasis of HCC cells in which NET1 has been stably knocked down. Additionally, to provide targets for therapeutic intervention, we aimed to identify the protein which interacts with NET1. NET1 knockdown significantly reduced the migration, invasion, and metastasis of MHCC-97H cells by 44, 65, and 77%, respectively, while cell proliferation was not significantly altered following NET1 knockdown. During our efforts to find potential NET1 modulators through protein-protein interactions, we identified merlin as a NET1-binding protein in a yeast two-hybrid screen. The interaction between NET1 and merlin was confirmed by co-immunoprecipitation. We found that the levels of NET1 protein decreased along with the increase of merlin levels. Furthermore, we demonstrated that merlin facilitates NET1 ubiquitination via the ubiquitin-proteasome pathway. Taken together, this study suggests that NET1 plays an important role in HCC cell migration, invasion, and metastasis, which are key aspects of HCC progression. Furthermore, merlin may serve as a tumor suppressor for HCC by facilitating ubiquitination of NET1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.